LivaNova (BSP:L2IV34) Cyclically Adjusted PS Ratio: (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:L2IV34 LivaNova PLC BSP:L2IV34
11 GF Score
Price R$52.47
GF Value R$40.71
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


LivaNova  (BSP:L2IV34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LivaNova Cyclically Adjusted PS Ratio Related Terms


LivaNova Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for LivaNova's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Cyclically Adjusted PS Ratio Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.82 2.69 2.31 1.92 2.37

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.61 1.79 2.06 2.37 2.45

BSP:L2IV34 vs IRTC, HAE, ITGR: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PS Ratio falls into.


BSP:L2IV34
11GF Score
LivaNova PLC BSP:L2IV34
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LivaNova's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, LivaNova's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=33.864/140.8000*140.8000
=33.864

Current CPI (Mar. 2026) = 140.8000.

LivaNova Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 22.356 101.000 31.166
201609 19.573 101.500 27.152
201612 4.214 102.200 5.806
201703 14.724 102.700 20.186
201706 17.455 103.500 23.746
201709 16.216 104.300 21.891
201712 18.723 105.000 25.107
201803 16.693 105.100 22.363
201806 21.974 105.900 29.216
201809 22.985 106.600 30.359
201812 23.762 107.100 31.239
201903 19.965 107.000 26.272
201906 22.107 107.900 28.848
201909 22.666 108.400 29.441
201912 24.384 108.500 31.643
202003 24.286 108.600 31.487
202006 19.447 108.800 25.167
202009 26.647 109.200 34.358
202012 28.522 109.400 36.708
202103 28.629 109.700 36.745
202106 27.182 111.400 34.356
202109 25.915 112.400 32.463
202112 28.659 114.700 35.180
202203 22.062 116.500 26.664
202206 23.722 120.500 27.718
202209 24.742 122.300 28.485
202212 26.967 125.300 30.303
202303 25.455 126.800 28.265
202306 26.426 129.400 28.754
202309 26.172 130.100 28.325
202312 27.868 130.500 30.068
202403 27.192 131.600 29.093
202406 31.431 133.000 33.274
202409 32.274 133.500 34.039
202412 35.884 135.100 37.398
202503 33.525 136.100 34.683
202506 35.736 138.400 36.356
202509 34.787 138.900 35.263
202512 36.060 139.900 36.292
202603 33.864 140.800 33.864

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is LivaNova (BSP:L2IV34) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of R$52.47 is trading 28.9% above its estimated GF Value™ of R$40.71. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for BSP:L2IV34:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: R$40.71 vs. price of R$52.47 (28.9% above fair value)
  • GF Score™: 11/100 with 7 warning signs

No single metric tells the full story. See the BSP:L2IV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LivaNova Business Description

Other Exchanges LIVN:USALIA:Germany
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
11GF Score

Get the complete analysis for BSP:L2IV34

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.47
Price
R$40.71
GF Value